Home
Storia in 1 fonti
Jarden upgrades Healius Limited (PGZ) to a Hold
Healius Limited received a Hold rating and a A$0.50 price target from Jarden analyst Steven Wheen on August 20. The company’s shares closed yest...
Raccontata da
markets.businessinsider.com
Timeline cronologica
- ·
Jarden Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)
In a report released yesterday, Steven Wheen from Jarden maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$20.70. The c...
- ·
Jarden upgrades Healius Limited (PGZ) to a Hold
Healius Limited received a Hold rating and a A$0.50 price target from Jarden analyst Steven Wheen on August 20. The company’s shares closed yest...